| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2005 | US6890744 Nucleotide sequences coding transcription factor for use in generation of lysine for use in animal nutrients the foods |
| 05/10/2005 | US6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses |
| 05/10/2005 | US6890738 Prolactin antagonists and uses thereof |
| 05/10/2005 | US6890737 For prognosing/monitoring efficiency of treatment of chronic hepatitis/natural disease; genetic engineering |
| 05/10/2005 | US6890735 TSG-like gene |
| 05/10/2005 | US6890734 Nucleic acids encoding a cytokine receptor complex |
| 05/10/2005 | US6890733 MEKK1 (serine threonine kinases)-interacting FHA (forkhead associated domain) protein 1 (M1F1) |
| 05/10/2005 | US6890731 For drug screeing/therapy of diseases; bacteriophages |
| 05/10/2005 | US6890730 For enhanced biomass production/secretion; fusion proteins/ membranes |
| 05/10/2005 | US6890725 Proteins; antiproliferative agent; autoimmune disease; antiinflammatory agents |
| 05/10/2005 | US6890720 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis |
| 05/10/2005 | US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease |
| 05/10/2005 | US6890713 For improving the effectiveness of chemotherapy; drug screening/design |
| 05/10/2005 | US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis |
| 05/10/2005 | US6890709 For induction of S-phase/oncogenicity/transcription/apoptosis in cells |
| 05/10/2005 | US6890565 Extracting coagulant protein derivatives from seeds of trees within the family Moringaceae especially those of Moringa oleifera Lam (syns Moringa pterygosperma Gaertn.) |
| 05/10/2005 | US6890542 The use of a live mutant Leishmania in the preparation of a vaccine and to vaccine formulations for use in immunising mammals, such as dogs and/or humans. The mutant Leishmania comprises at least one defective cysteine proteinase gene. |
| 05/10/2005 | US6890539 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections |
| 05/10/2005 | US6890537 Antigrowth agents; microbiocides, bactericides |
| 05/10/2005 | US6890536 Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
| 05/10/2005 | US6890535 Pharmaceutical compositions and methods for treatment of amyloid diseases |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890531 Neuronal growth factor galectin-1 |
| 05/10/2005 | US6890528 Cells for the production of helper dependent adenoviral vectors |
| 05/10/2005 | US6890518 Compositions of chemically modified insulin |
| 05/10/2005 | US6890516 Identifying a substance capable of affecting long term memory in an animal comprising the determination that said substance alters activator homodimer, activator-repressor heterodimer and/ or repressor homodimer formation from normal |
| 05/10/2005 | US6890515 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/10/2005 | US6890512 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2123579C Recombinant multivalent m protein vaccine |
| 05/10/2005 | CA2116559C Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 05/10/2005 | CA2116192C Highly concentrated tcf pharmaceutical preparations |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040821A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 18 (gpr18) |
| 05/06/2005 | WO2005040799A1 Artificial antibody comprising complementary peptide |
| 05/06/2005 | WO2005040426A1 Molecular marker associated with cmv resistance and use thereof |
| 05/06/2005 | WO2005040418A2 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt |
| 05/06/2005 | WO2005040384A1 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 05/06/2005 | WO2005040383A1 B lymphoid lineage specific promoter sequences and pharmaceutical compositions containing the same |
| 05/06/2005 | WO2005040380A1 Rodent immune response regulatory proteins |
| 05/06/2005 | WO2005040375A1 A fungal immuromodulatory protein produced by microorganisme and uses thereof |
| 05/06/2005 | WO2005040368A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 05/06/2005 | WO2005040365A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 05/06/2005 | WO2005040359A1 Vaccine for periodontal disease |
| 05/06/2005 | WO2005040356A2 Mutant p53 protein and uses thereof |
| 05/06/2005 | WO2005040353A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | WO2005040352A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 05/06/2005 | WO2005040349A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | WO2005040344A2 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 05/06/2005 | WO2005040341A2 Human prostaglandin ep4 receptor variants and methods of using same |
| 05/06/2005 | WO2005040335A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 05/06/2005 | WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | WO2005040229A2 Ldl receptor class a and egf domain monomers and multimers |
| 05/06/2005 | WO2005040218A1 METHOD FOR PREPARING COMPOSITE IgY SPECIFIC AGAINST PERIODONTAL DISEASE AND COMPOSITE PREPARATION THEREOF |
| 05/06/2005 | WO2005040215A2 Ovomucoid promoters and mehtods of use |
| 05/06/2005 | WO2005040214A1 Virally-safe factor viii with a low content of higher multimers |
| 05/06/2005 | WO2005040213A1 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES |
| 05/06/2005 | WO2005040212A2 Orthogonal gene switches |
| 05/06/2005 | WO2005040210A2 Novel cxcl8 antagonists |
| 05/06/2005 | WO2005040209A1 Human chemokine hcc-1 polypeptides to improve stem cell transplantation |
| 05/06/2005 | WO2005040208A2 Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use |
| 05/06/2005 | WO2005040207A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family |
| 05/06/2005 | WO2005040206A1 Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| 05/06/2005 | WO2005040205A1 Peptides with anti-obesity activity and other related uses |
| 05/06/2005 | WO2005040204A1 A tumor-inhibiting protein and the use thereof |
| 05/06/2005 | WO2005040203A2 Msp-3-like family of genes |
| 05/06/2005 | WO2005040202A2 Stabilized alpha-helical peptides |
| 05/06/2005 | WO2005040201A1 Human cathelicidin antimicrobial peptides |
| 05/06/2005 | WO2005040200A1 Protein expression |
| 05/06/2005 | WO2005040199A1 A bidentate motif and methods of use |
| 05/06/2005 | WO2005040198A1 A binding motif and methods of regulating cell function |
| 05/06/2005 | WO2005040197A1 Compositions, methods and kits for biarsenical fluorophore labeling |
| 05/06/2005 | WO2005040195A2 Formulation of exendins |
| 05/06/2005 | WO2005040194A2 Methods and compositions for pdgf-c activation and inhibition |
| 05/06/2005 | WO2005040193A2 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 05/06/2005 | WO2005040192A2 Human cathelicidin antimicrobial peptides |
| 05/06/2005 | WO2005040191A2 Ccn1 compositions and methods |
| 05/06/2005 | WO2005039644A1 Method of transferring soluble interferon ϝ receptor gene and composition for preventing or treating arteriosclerosis |
| 05/06/2005 | WO2005039643A2 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | WO2005039633A1 Agent for treating leishmania infections |
| 05/06/2005 | WO2005039632A1 Colorectal cancer antigen |
| 05/06/2005 | WO2005039631A1 Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses |
| 05/06/2005 | WO2005039618A1 p185neu-ENCODING DNA AND THERAPEUTICAL USES THEREOF |
| 05/06/2005 | WO2005039616A1 Angiogenic peptides and uses thereof |
| 05/06/2005 | WO2005039613A1 Lim2 inhibitor of lm02 |
| 05/06/2005 | WO2005039607A1 The use of balloonfish collagen i extractive in medical care and the preparative method of it |
| 05/06/2005 | WO2005039501A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/06/2005 | WO2005030240A3 Vege-cor vege-d materials and methods for stimulation of neural stem cells |
| 05/06/2005 | WO2005023834A3 Peptides and compounds that bind to thrombopoietin receptors |
| 05/06/2005 | WO2005019454A8 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 05/06/2005 | WO2005017161A3 Chimeric peptides for the regulation of gtpases |
| 05/06/2005 | WO2005014622A3 Ra antigenic peptides |
| 05/06/2005 | WO2005005467A3 Novel immune booster compound comprising an ef adenoviral sequence |
| 05/06/2005 | WO2005004592A3 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2004112727A3 Aav virions with decreased immunoreactivity and uses therefor |
| 05/06/2005 | WO2004097425A3 Method of selecting chemokine antagonists and agonists |
| 05/06/2005 | WO2004094622A3 Extracellular messengers |
| 05/06/2005 | WO2004093830A3 Model for neurodegenerative disorders |
| 05/06/2005 | WO2004093785A3 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |